1/103
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
pMDIs (pressurized metered dose inhalers)
evaporation of propellant when inhaler is actuated
how do you breathe with pMDIs
slow and deep to fill lungs to capacity. hold breath prior to exhalation for more drug entry and more time for the drug to settle
what is the critical requirement for pMDIs
coordination
what do you use if a pt cannot coordinate?
Use a spacer, this helps aerosols travel a little longer. The bigger particles will not go into the lungs.
what are the dosage forms for pMDIs
solutions or suspensions
DPIs (dry powder inhalers)
drug preloaded into the device or filled into a hard capsule or foil blister which is loaded prior to use
breath pattern for DPIs
fast and deep. must breathe fast enough to cause aerosolization
disadvantage of DPIs
can cause pt to cough due to breathing in "dust"
drug loss due to impaction
dosage forms of DPIs
unit dose or multi-dose , powders in blisters or capsules
nebulizers
generates droplets of aerosols
breath pattern for nebulizers
inhaled during normal tidal breathing, no specific pattern
dosage forms of nebulizers
solutions or suspensions
when to rinse your mouth
when using corticosteroids
Determine the product: has a propellant like HFA
pMDI
Determine the product: powder form and sometimes contains lactose
DPI
Determine the product: a nebulizer machine is needed and it looks like normal suspensions or solutions
nebulizer
advantages of pMDI
no contamination risk, easy to use, compact, accurate
disadvantages of pMDI
specific techniques, dose limit, contamination risk due to spacers
advantages of DPI
no specific coordination, propellant unnecessary
disadvantages of DPI
can trigger coughing (inhaling dust)
dose depends on inhalation rate
advantages of nebulizer
used with most drug solutions
no specific inhalation
allows for larger doses
disadvantages of nebulizers
time consuming
high risk for contamination
bulky
not easily portable
role of a spacer
extension device that helps reduce inhalation/actuation coordination dependency , slows down the velocity and allows for more time for the propellant to evaporate and reduce the particle size of the aerosol
who uses spacers
patients who have difficulty coordinating using pMDIs
can also use nebulizers with pMDIs and patients who are unable to coordinate.
which inhalation product contains lactose
DPI
what is lactose used for
used as a carrier: micronized drugs are attached to the carrier and placed in a capsule or blister; when it is actuated by pressing a button, it is punctured and holes are made; when the patient inhales fast, the turbulent air will cause the detachment of drug from the carrier; only the drug will go to the lung and the lactose carrier will not
instructions for pMDI
shake, hold, exhale, inhale slowly, hold breath for 10 seconds
instructions for DPI
fast and deep breath; hold for 10 seconds. do not swallow capsules, rinse mouth after use to prevent oral thrush due to corticosteroids
advantages of pulmonary delivery
bypasses 1st pass metabolism, reduces adverse drug reactions, and manages airway diseases due to being selective towards receptors in the lungs versus receptors in the other areas of the body
fast onset of action, low drug dose needed
requires sterility and particulate matter testing, but no requirement for bacterial endotoxin testing
desired range of aerodynamic diameter of aerosols for pulmonary delivery
1-5 um
mechanism for aerosols to deposit
gravitational sedimentation for the size between 1-5um
mechanism for aerosols to lose
inertial impaction for the size > 5 um, and Brownian diffusion for the size < 1um
how can breathing patterns impact how much drug is able to reach the desired target
slow breath to reduce loss due to inertial impaction
deep breath (good for all) will allow for more air to get into the lung and thus more drug (which is dispersed in the air) will enter the lung
breath holding (good for all) will give more time for the drug to disperse in the air to settle to the surface of the lung for action either locally or systematically
loading dose is not the expected dose, dose depends on the patient and how well they breathe it in
dosage forms for IV products
aqueous solutions or o/w emulsions (water is external phase can be miscible with blood)
dosage forms for SubQ products
aqueous solutions and suspensions
dosage forms for IM products
aqueous or oily solutions & suspensions
intramuscular injection: oily suspensions & solutions
must partition first (if using oil)
if using aqueous (solutions) everything is soluble so need to mix
only IM allows for the oil to be used as a vehicle (slower, lasts longer)
suspension: drug needs to dissolve first
sterility
this is a test that is required
must be absent of viable microbes
must add preservatives for multi-dose vials
can be preservative free for single-dose
particulate matter
testing is required and must be particulate free
meet USP requirements (method: count numbers of particles)
solutions must be free from particulate matter > 10 um
check for visible particulates > 50um before use
want it to be clear
endotoxins
not zero tolerance, can have a certain quantity as long as the number does not exceed the limit (EU limit)
definition: a by-product of bacteria & very hard to move
must have dry heat and time to destroy (to eliminate)
pH for parenteral products
7.4
doesn't have to be this exactly, just within that range
tonicity: 0.9% NaCl
desired, but can be within an acceptable range
general consideration for parenteral products
the types of excipients required for nonsterile products still apply, but not all excipients in each type can be used; should check in an excipient can be used in parenteral products and what is the amount limit
specific considerations in selecting water and vehicles for dissolving drugs
sterile water for injection
*not for IV due to having no tonicity
specific considerations in selecting water and vehicles for flushing tubing
sterile water for injection
specific considerations in selecting water and vehicles for preparing dilutions for intravenous administration
sodium chloride injection: isotonic, sterile for IV (using normal saline only)
0.9% sodium chloride for injection
specific considerations in selecting water and vehicles for small volume injection or flushing
bacteriostatic water & bacteriostatic NaCl (not for use in neonates) already has preservatives
contains antimicrobial agents
do not use a larger volume for this, if you do then you will have larger preservatives, and the more/larger of your preservatives the more toxic it will be (esp. benzyl alcohol)
can you have coloring agents in parenteral products
NO GIRL
sterilization methods: steam
first choice
terminal or autoclave
heat + moisture
can't use oil (oleaginous preparations) because no water can get in
sterilization methods: dry heat
heat stable powder
for oils, fats & oleaginous preparations
for depyrogenation
destroying pyrogens that's within endotoxins
sterilization methods: ionizing radiation
doesn't generate heat
use if substance cannot tolerate heat
sterilization method: gaseous
can be toxic to operators
terminal
sterilization method: sterilization by filtration
0.22 um (for solutions only)
non-terminal
for solutions & gases
can't use emulsions or suspensions
most used in sterile compounding
commonly used containers
glass or plastic
can you have mutli-dose and single dose
YES
glass
more inert (not reactive) preferred over plastic
must be transparent
type 1 preferred for glass and doesn't cause any changes with product
most resistant to chemical deterioration
type 2 or 3 can be used with some products
plastic
less inert = more reactive
free of DEHP due to the DEHP bc it can cause contamination
can be made out of PVC. If it is, then you will have DEHP, which will leach out, contaminating the solution. When product contains cosolvent, it can cause a lot of toxicity.
can be made out of different materials, if made out of this material then it will not have DHEP
want to use latex-free products for rubber closure (due to human allergies bc rubber has latex)
SVP (small volume parenteral)
single-dose injections packaged in containers
volume is 100ml or Less
LVP (large volume parenteral)
no preservatives (bc of toxicity), single-dose injection for IV use, no bacteriostatic agents
volume > 100ml
TPN (total parenteral nutrition) & TNA (total nutrient admixture)
provides essential nutrients (carbs from dextrose, protein from AA, multivitamins from trace elements, eetc & lipid from lipid emulsion)
TNA
amino acid, dextrose, + other trace elements (lipid o/w type is included). same container
can use normal infusion (depends on osmolarity)
TPN
high concentration & high osmolarity (use central vein)
PPN (peripheral parenteral nutrition)
low concentration & low osmolarity
still hypertonic but less hypertonic than TPN, thus can use peripheral vein if there is no lipid added)
type of injectable lipid emulsions
o/w so it can dissolve in the water (water is external phase and blood is water) you want it to be miscible in blood (not dissolved)
filter needle size
5 um
sterilization filtration needle size
0.22 um
administration with TNA size
1.2 um because TNA contains the lipid emulsion
if you use 0.22 um then it wont pass through it, it will remove everything through the filter; everything will be bigger than that filter size
what factors increase the risk of precipitation of calcium phosphate TPNs
pH = lower, for soluble one, pH of final should never be higher = precipitation occurred
temp = lower
Ca2+ = lower for soluble one
AA = higher, for soluble one
what type of dosage forms are insulins
solutions or suspensions
what are the proper administration instructions for insulin products
rotate gently, do not shake
ensure its clear for solution or uniformly cloudy for suspension
do not place in a freezer or leave in heat because it can denature
rotate site of injection, if you didn't rotate then it will decrease absorption
What are the requirements for sterile compounding facilities in terms of ISO class of air and disinfection?
perform in ISO Class 5 (just remove particles, not sterilize)
disinfect everything
ensure sterility and particulate free
What is primary engineering control (PEC) critical sites, first air, & laminar airflow workbench (LAFW)?
ensure it is exposed to air, so first air can blow out parts at anytime (no blocking)
syringe (tip of needle), needle, vial and ampules, additive bags
*critical sites are the parts of supplies and bags that have greater risk of contamination, subsequently causing the contamination of CSPs, such as tip of needle, rubber closure of vial, ampule opening, and additive port of IV bag
first air = air comes from HEPA filter, air blows out particles, no blocking in the air, be aware of direction so you know how to position supplies that are critical sites
laminar airflow workbench = first air for compounding
disinfection is required: everything must be sterilized (bench, hood, glove, all supplies, even the injection site)
Is disinfection required for PEC?
disinfection is required, everything must be sterilized (bench, hood, glove, all supplies, even the injection site)
How do you classify the risk level of compounded sterile preparations (CSP)?
Classify risk levels by ingredients/admixtures (how much is added)
What CSPs are considered high risk and must be sterilized?
high risk: admixtures with nonsterile ingredients; whenever you use something nonsterile
What are the required tests for these high-risk CSPs?
sterility test, bacterial endotoxin test, particulate matter test
steps of aseptic technique
gather supplies
disinfect everything
prepare syringes (open everything and ensure critical sites are properly facing airflow)
enter vials (avoid coring - pieces of rubber come into solution if not injected properly)
withdraw from an ampule (using a filtered needle, ALWAYS, may inject glass if not)
inject into solutions (never use the same filter needle to withdraw and inject); allow the port to dry first after disinfecting (disinfect before any injection), then inject, don't puncture the bag. do not use the filter needle; filter needle is only used when withdrawing solution from an ampule
Cover & label product: main label & auxiliary label
What are the specific considerations in the following?
Required by all: no critical sites are touched, the flow of first air to critical sites must be maintained
specific considerations to enter and withdraw from a vile
rubber closure should be wiped before puncture
prevent coring (rubber pieces getting into solution and causing contamination)
withdrawing: add equal amount of air as the volume to be withdrawn to the vile
-if more air added = positive pressure and solution with spray out
-if less air added = negative pressure
specific considerations for withdrawing from an ampule
the neck should be wiped before breaking
tap the neck to move contents into the body
breakneck (not towards HEPA filter)
use a filter needle with a bevel downward and then change to a regular needle
specific considerations to add a drug solution to LVP or SVP
remove protective covering from medication port and aseptically withdraw drug
wipe medication port with alcohol 1st (rubber closure)
insert needle into port and inject additive solution
remove needle
specific considerations to reconstitute a drug powder
Sterile water for injection is preferred as a dilutent to dissolve: rotate or swirl to dissolve, not shake; check for complete dissolving
consider powder volume to know how much diluent needs to be added
vehicle is added with 2steps
wipe rubber closure first, consider coring, never shake, swirl to dissolve then check for clarity to ensure dissolution
specific considerations to thaw a frozen drug
if frozen, just thaw at room temperature or in a fridge
never use a waterbath or microwave
specific considerations to mix parenteral products
always check compatibility 1st (big concern)
mix completely after each addition of an ingredient
do not shake but rotate or swirl
specific considerations to inject parenteral preparation to a patient
site should be cleaned and disinfected
site should be rotated if frequent injections are needed
specific considerations to inspect CSPs after compounding and before administration
check particulate matter
any signs of incompatibility such as color change, precipitation, emulsion cracking
if supposed to be clear then it should be clear
preparation for lab
melt
suspend
colors/flavors PRN
pour into mold
emulsion
emulsifying agent ALWAYS
may shake
acacia emulsion (o/w)
cannot mix all together, follow order of addition
primary emulsion first then add all of the other ingredients & QS
emulsion procedure
4:2:1 ratio of oil:water:acacia
must form a primary emulsion first(key)
triturate acacia and oil in a dry ceramic mortar
measure water & add all at once with hard & fast trituration
continue until a thick white liquid is formed with a cracking sound
then gradual dilution with trituration
transfer the diluted emulsion to a cylinder
rinse & add water to the final volume
lime water emulsion
tweens and spans
just mix together
gel
must add gelling agent
Carbapol gel
challenging, must make a clear gel so you must neutralize, do not over neutralize may precipitate
gel procedure
start with water in a beaker
with magnetic stirring, sift carbapol to water
add trolamine dropwise while stirring with a glass rod to from a clear and viscous gel. measure pH, do not over neutralize (pH 6-7)
add water to the final weight as needed
ointment
no matter what base, always melt everything using a water bath (fusion method)
mixing/reaction must happen in the molten state
water phase and oil phase ointment
mix after melting,
water into oil
PEG ointment
even though 1 is a liquid, must melt them together & mix at a temperature higher than mp, allow to congeal
suppository
for perianal use
fatty base suppository
cocoa butter
key: unstable (can easily form metastable form) melting in room temp or in your hand
heat must be controlled
monitor appearance of molten liquid, should not be clear bc then it will not form a good suppository (since metastable in already formed)
water soluble base (PEG)
melt together, mix well at molten state, pour into mold if it melts at very high temperature takes longer to congeal